| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.24 | 8e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.1 |